Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada
Immunotherapy and targeted therapies have been shown to considerably improve long-term survival outcomes in metastatic melanoma patients. Real-world evidence on the uptake of novel therapies and outcomes for this patient population in Canada are limited. We conducted a population-based retrospective...
Main Authors: | Dylan E. O’Sullivan, Devon J. Boyne, Priyanka Gogna, Darren R. Brenner, Winson Y. Cheung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/30/4/317 |
Similar Items
-
Real-World Treatment Patterns, Clinical Outcomes, and Health Care Resource Utilization in Extensive-Stage Small Cell Lung Cancer in Canada
by: Dylan E. O’Sullivan, et al.
Published: (2021-08-01) -
Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis
by: Rodrigo Rigo, et al.
Published: (2021-10-01) -
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
by: Saba S. Shaikh, et al.
Published: (2022-11-01) -
CURRENT CONCEPTS IN THERAPY OF UVEAL MELANOMA
by: Detanac Dženana A, et al.
Published: (2015-07-01) -
Molecular Insights and Emerging Strategies for Treatment of Metastatic Uveal Melanoma
by: Fabiana Mallone, et al.
Published: (2020-09-01)